Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic versus branded citalopram 20 mg pharmacokinetic bioavailability crossover study in healthy Chinese CYP2C19 extensive metabolizers
ChiCTR-TRC-12001893Phase 4Completed
- Sponsor
- Sandoz
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of citalopram in major depressive disorder (MDD) (2 arms), sponsored by Sandoz. Primary endpoint: Pharmacokinetic property. Started Dec 2007; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-TRC-12001893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001893.